HomeComparePRCIX vs JNJ

PRCIX vs JNJ: Dividend Comparison 2026

PRCIX yields 4.46% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PRCIX wins by $6.8K in total portfolio value
10 years
PRCIX
PRCIX
● Live price
4.46%
Share price
$7.94
Annual div
$0.35
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.8K
Annual income
$594.30
Full PRCIX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PRCIX vs JNJ

📍 PRCIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPRCIXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PRCIX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PRCIX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRCIX
Annual income on $10K today (after 15% tax)
$379.46/yr
After 10yr DRIP, annual income (after tax)
$505.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $198.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRCIX + JNJ for your $10,000?

PRCIX: 50%JNJ: 50%
100% JNJ50/50100% PRCIX
Portfolio after 10yr
$23.4K
Annual income
$711.04/yr
Blended yield
3.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PRCIX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRCIX buys
0
JNJ buys
0
No recent congressional trades found for PRCIX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPRCIXJNJ
Forward yield4.46%3.36%
Annual dividend / share$0.35$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$26.8K$20.0K
Annual income after 10y$594.30$827.78
Total dividends collected$5.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PRCIX vs JNJ ($10,000, DRIP)

YearPRCIX PortfolioPRCIX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,146$446.42$10,676$355.77+$470.00PRCIX
2$12,392$465.05$11,407$389.39+$985.00PRCIX
3$13,742$483.18$12,198$426.53+$1.5KPRCIX
4$15,205$500.79$13,056$467.62+$2.1KPRCIX
5$16,787$517.85$13,987$513.12+$2.8KPRCIX
6$18,497$534.33$14,998$563.56+$3.5KPRCIX
7$20,342$550.22$16,098$619.52+$4.2KPRCIX
8$22,331$565.52$17,295$681.69+$5.0KPRCIX
9$24,475$580.21$18,599$750.82+$5.9KPRCIX
10$26,782$594.30$20,022$827.78+$6.8KPRCIX

PRCIX vs JNJ: Complete Analysis 2026

PRCIXStock

The investment seeks to maximize total return through income and capital appreciation. The fund will invest at least 80% of its net assets in income-producing securities, which may include, but are not limited to, U.S. government and agency obligations, mortgage- and asset-backed securities (including commercial mortgage- backed securities), corporate bonds, foreign bonds, and Treasury inflation protected securities.

Full PRCIX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PRCIX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRCIX vs SCHDPRCIX vs JEPIPRCIX vs OPRCIX vs KOPRCIX vs MAINPRCIX vs ABBVPRCIX vs MRKPRCIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.